Trifluperazine 5 mg,Trihexiphenidyl 2 mg & Chlorpromazine 50 mg

Get a Price/Quote

MOQ : 15-30 Boxes

Trifluperazine 5 mg,Trihexiphenidyl 2 mg & Chlorpromazine 50 mg Specification

Drug Type
Specific Drug

Ingredients
Alprazolam 0.25 mg & Fluoxetine 20 mg

Physical Form
Tablets

Function
Other

Recommended For
Schizophrenia, Psychotic Disorder

Trifluperazine 5 mg,Trihexiphenidyl 2 mg & Chlorpromazine 50 mg Trade Information

Minimum Order Quantity
15-30 Boxes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Alu-Alu/ Blister, 20*10 Tablet Packing

Main Export Market(s)
Australia, North America, South America, Eastern Europe, Western Europe, Middle East, Central America, Asia, Africa

Main Domestic Market
All India

Certifications
WHO-GMP

Trifluperazine 5 mg,Trihexiphenidyl 2 mg & Chlorpromazine 50 mg About

Trifluperazine 5 mg, Trihexiphenidyl 2 mg & Chlorpromazine 50 mg tablets are formulated to support mental health treatments for conditions such as schizophrenia and psychotic disorders. These tablets contain potent, clinically-tested ingredientsTrifluperazine helps manage psychotic symptoms and emotional instability; Trihexiphenidyl is beneficial in controlling movement disorders caused by certain medications; and Chlorpromazine provides relief from mood disturbances and delusions associated with psychotic conditions. Designed for adults and aged individuals, these specific drugs present in physical tablet form ensure convenience and ease of dosage. Manufactured under stringent quality control measures, they offer reliable therapeutic efficacy to address complex psychiatric needs. Recommended for medical use under professional supervision, the composition is optimized for targeted mental health management in patients.